Glucocorticoid excess affects cortical bone geometry in premenopausal, but not postmenopausal, women

Calcified Tissue International

Volumn 82, Issue 3, 2008, Pages 182-190

  Kaji, Hiroshi ^a   Yamauchi, Mika ^b   Chihara, Kazuo ^a   Sugimoto, Toshitsugu ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Bone geometry; Cushing syndrome; Fracture; Glucocorticoid

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BONE ATROPHY; BONE MASS; BONE STRENGTH; BONE STRUCTURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; CORTICOSTEROID BLOOD LEVEL; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DISEASE PREDISPOSITION; DRUG EFFECT; ENTERITIS; FEMALE; FOREARM; GRANULOMATOSIS; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT DISEASE; RISK FACTOR; SKIN DISEASE; VERTEBRA FRACTURE;

ADMINISTRATION, ORAL; ADULT; CUSHING SYNDROME; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PERIOSTEUM; POSTMENOPAUSE; PREDNISOLONE; PREMENOPAUSE; SPINAL FRACTURES; SPINE; TOMOGRAPHY, X-RAY COMPUTED; ULNA;

EID: 41049105967     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-008-9106-9     Document Type: Article

References (50)

1. Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Pecock N, Yeates M, Eisman J (1990) Corticosteroid effects on proximal femur bone loss. J Bone Miner Res 5:1211-1216
2. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224-3229
3. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000
4. Steinbuch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15:323-328
5. Van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777-787
6. Kanis JA, Johansson H, Oden AM, Johnell O, de Laet C, Melton LJ III, Tenenhouse A, Reeve J, Silman AJ, Pols HAP, Eisman JA, McCloskey EV, Mellstrom D (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893-899
7. Manelli F, Giustina A (2000) Glucocorticoid-induced osteoporosis. Trends Endocrinol Metab 11:79-85
8. Kaltsas G, Manetti L, Grossman AB (2002) Osteoporosis in Cushing's syndrome. Front Horm Res 30:60-72
9. Manning PJ, Evans MC, Reid IR (1992) Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol 36:229-234
10. Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 80:2859-2865
11. Mancini T, Doga M, Mazziotti G, Giustina A (2004) Cushing's syndrome and bone. Pituitary 7:243-246
12. Francucci CM, Pantanetti P, Garrapa GG, Massi F, Arnaldi G, Mantero F (2002) Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma. Clin Endocrinol 57:587-593
13. Vestergaard P, Lindholm J, Jorgensen JOL, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Kristensen LO, Feldt-Rasmussen U, Mosekilde L (2002) Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol 146:51-56
14. Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research. J Bone Miner Metab 23:105-109
15. Kaji H, Yamauchi M, Chihara K, Sugimoto T (2006) The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis. Endocr J 53:27-34
16. NIH Consensus Development Panel on Osteoporosis Prevention. Osteoporosis prevention, diagnosis, and the therapy. JAMA 285:785-795
17. Lehmann R, Wapniarz M, Kvasnicka HM, Baedeker S, Klein K, Allolio B (1992) Reproducibility of bone density measurements of the distal radius using a high resolution special scanner for peripheral quantitative computed tomography (Single Energy PQCT). Radiology 32:177-181
18. Martin RB (1991) Determinants of the mechanical properties of bones. J Biomech 24(Suppl 1):79-88
19. Smith RW Jr, Walker RR (1964) Femoral expansion in aging women: implications for osteoporosis and fractures. Science 145:156-157
20. Ahlborg HG, Johnell O, Turner CH, Rannevik G, Karlsson MK (2003) Bone loss and bone size after menopause. N Engl J Med 349:327-334
21. Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K (2003) Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 88:4655-4658
22. Kaji H, Kosaka R, Yamauchi M, Kuno K, Chihara K, Sugimoto T (2005) Effects of age, grip strength and smoking on forearm volumetric bone mineral density and bone geometry by peripheral quantitative computed tomography: comparisons between female and male. Endocr J 52:659-666
23. Riggs BL, Melton LJ III, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, Rouleau PA, McCollough CH, Bouxsein ML, Khosla S (2004) Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res 19:1945-1954
24. Tsugeno H, Fujita T, Goto B, Sugishita T, Hosaki Y, Ashida K, Mitsunobu F, Tanizaki Y, Shiratori Y (2002) Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis. Osteoporos Int 13:650-656
25. Lian KC, Lang TF, Keyak JH, Modin GW, Rehman Q, Do L, Lane NE (2005) Differences in hip quantitative computed tomography (QCT) measurement on bone mineral density and bone strength between glucocorticoid-treated and glucocortiocid-naïve postmenopausal women. Osteoporos Int 16:642-650
26. Smith-Bindman R, Cummings SR, Steiger P, Genant HK (1991) A comparison of morphometric definitions of vertebral fractures. J Bone Miner Res 6:25-34
27. Ruegsegger P, Durand E, Dambacher MA (1991) Localization of regional forearm bone loss from high-resolution computed tomographic images. Osteoporos Int 1:76-80
28. Schiessl H, Ferretti JL, Tysarczyk-Niemeyer G (1996) Noninvasive bone strength index as analysis by peripheral quantitative computed tomography (pQCT). In: Schonau E (ed) Pediatric osteology. New developments in diagnostics and therapy. Elsevier, Amsterdam, pp 147-160
29. Ashizawa N, Nonaka K, Michikami S, Mizuki T, Amagai H, Tokuyama K, Suzuki M (1999) Tomographical description of tennis-loaded radius: reciprocal relation between bone size and volumetric BMD. J Appl Phys 86:1347-1351
30. Ørtoft G, Oxlund H (1996) Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid. Bone 18:581-590
31. Ikeda S, Morishita Y, Tsutsumi H, Ito M, Shiraishi A, Arita S, Asahoshi S, Narusawa K, Nakamura T (2003) Reductions in bone turnover, mineral, and structure associated with mechanical properties of lumbar vertebra and femur in glucocorticoid-treated growing minipigs. Bone 33:779-787
32. Kaji H, Tobimatsu T, Naito J, Iu MF, Yamauchi M, Sugimoto T, Chihara K (2006) Body composition and vertebral fracture risk in female patients treated with glucocorticoid. Osteoporos Int 17:627-633
33. Michel BA, Bloch DA, Wolfe F, Fries JF (1993) Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 20:1666-1669
34. Ramsey-Goldman R, Dunn JE, Huang CF, Dunlop P, Rairie JE, Fitzgerald S, Manzi S (1999) Frequency for fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum 42:882-890
35. Faggiano A, Pivonello R, Filippella M, Di Somma C, Orio F Jr, Lombard G, Colao A (2001) Spine abnormalities and damage in patients cured from Cushing's disease. Pituitary 4:153-161
36. Chiodini I, Carnevale V, Torlontano M, Fusilli S, Guglielmi G, Peleri M, Modoni S, Di Giorgio A, Liuzzi A, Minisola S, Cammisa M, Trischotta V, Scillitani A (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 83:1863-1867
37. Rubin MR, Bilezikian JP (2002) The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence. J Clin Endocrinol Metab 87:4033-4041
38. Unsi-Rasi K, Semanick IM, Zanchetta JR, Bogado CZ, Eriksen EF, Sato M, Beck IJ (2005) Effects of teriparatide [rhPTH(1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 36:948-958
39. Ferretti JL, Capozza RF, Mondelo N, Zanchetta JR (1993) Interrelationships between densitometric, geometric, and mechanical properties of rat femora: inferences concerning mechanical regulation of bone modeling. J Bone Miner Res 8:1389-1396
40. Myers ER, Hecker AT, Rooks DS, Hipp JA, Hayes WC (1993) Geometric variables from DXA of the radius predict forearm fracture load in vitro. Calcif Tissue Int 52:199-204
41. Oleksik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P (2000) Bone structure in patients with low bone mineral density with or without vertebral fractures. J Bone Miner Res 15:1368-1375
42. Yamauchi M, Sugimoto T, Chihara K (2004) Determinants of vertebral fragility: the participation of cortical bone factors. J Bone Miner Metab 22:79-85
43. Karavitaki N, Ioannidis G, Giannakopoulos F, Marvrokefalos P, Thalassinos N (2004) Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome. Clin Endocrinol 60:264-270
44. Di Somma C, Pivonello R, Loche S, Faggiano A, Klain M, Salvatore M, Lombardi G, Colao A (2003) Effect of 2 years of cortisol normalization on the impared bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study. Clin Endocrinol 58:302-308
45. Di Somma C, Pivonello R, Loche S, Faggiano A, Marzullo P, Di Sarno A, Klain M, Salvatore M, Lombardi G, Colao A (2002) Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease. Clin Endocrinol 56:153-158
46. Ruegsegger P, Medici T, Anliker M (1983) Corticosteroid-induced bone loss: a longitudinal study of alternate therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Parmacol 25:615-620
47. Seeman E (1997) From density to structure: growing up and growing old on the surfaces of bone. J Bone Miner Res 12:509-521
48. Russo CR, Lauretani F, Bandinelli S, Bartali B, Di Iorio A, Volpato S, Guralnik JM, Harris T, Ferrucci L (2003) Aging bone in men and women: beyond changes in bone mineral density. Osteoporos Int 14:531-538
49. Vanderschueren D, Venken K, Ophoff J, Bouillon R, Boonen S (2006) Sex steroids and the periosteum-reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endcocrinol Metab 91:378-382
50. Saxon LK, Turner CH (2006) Low-dose estrogen treatment suppresses periosteal bone formation in response to mechanical loading. Bone 39:1261-1267